Application 219705
- Type
- ANDA
- Sponsor
- SANDOZ INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | AXITINIB | AXITINIB | TABLET | 1MG | No | No |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| INLYTA | AXITINIB | U.S. Pharmaceuticals | 8a903e31-936e-4ed7-8a59-59f32374f338 | 2026-03-12 | Warnings, Adverse reactions | AXITINIB |
| INLYTA | AXITINIB | Pfizer Laboratories Div Pfizer Inc | 84137882-e000-47da-bd5b-fa76ab3c76f9 | 2025-02-19 | Warnings, Adverse reactions | AXITINIB |